Milestone Scientific vs Anbio Biotechnology
Milestone Scientific and Anbio Biotechnology are similar in size: $9.0m and $8.6m of revenue in their latest fiscal years. Anbio Biotechnology grew faster (5.6% against 4.0%). Anbio Biotechnology kept more of each dollar of sales as profit: a net margin of 74.1% against -63.8%.
| Latest fiscal year | Milestone ScientificMLSS, 2025 | Anbio BiotechnologyNNNN, 2025 |
|---|---|---|
| Revenue | $9.0m | $8.6m |
| Revenue growth | 4.0% | 5.6% |
| Net income | −$5.7m | $6.4m |
| Operating margin | — | 66.7% |
| Net margin | -63.8% | 74.1% |
| Return on equity | -132.4% | 27.0% |
| Free cash flow | −$2.9m | — |
| Cash | $1.1m | $7.8m |
| Total debt | $800,000 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 15 | — |
| Market value | $28.4m | $153m |
| Price vs our value range | — | — |
| Moat score | 27 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |